Literature DB >> 21051302

Techniques for assessing cardiac output and fetal cardiac function.

Boris Tutschek1, Klaus G Schmidt.   

Abstract

Fetal echocardiography was initially used to diagnose structural heart disease, but recent interest has focused on functional assessment. Effects of extracardiac conditions on the cardiac function such as volume overload (in the recipient in twin-twin transfusion syndrome), a hyperdynamic circulation (arterio-venous malformation), cardiac compression (diaphragmatic hernia, lung tumours) and increased placental resistance (intrauterine growth restriction and placental insufficiency) can be studied by ultrasound and may guide decisions for intervention or delivery. A variety of functional tests can be used, but there is no single clinical standard. For some specific conditions, however, certain tests have shown diagnostic value. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21051302     DOI: 10.1016/j.siny.2010.09.005

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  6 in total

1.  Automated region mask for four-chamber fetal heart biometry.

Authors:  S Vijayalakshmi; N Sriraam; S Suresh; S Muttan
Journal:  J Clin Monit Comput       Date:  2012-10-21       Impact factor: 2.502

2.  The development of, and future for, fetal functional cardiac imaging techniques.

Authors:  Alec Welsh
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

3.  Prediction of pregnancy complication occurrence using fetal cardiac output assessments made by ultrasonography at 20 to 24 weeks of gestation.

Authors:  Ji Yeon Lee; Young Li Kim; Ji Eun Jeong; Jun Woo Ahn
Journal:  Obstet Gynecol Sci       Date:  2017-07-14

4.  Atrial and ventricular ejection force of the fetal heart: Which of the four chambers is the dominant?

Authors:  Elaheh Malakan Rad; Toktam Sheykhian; Ali Akbar Zeinaloo
Journal:  Ann Pediatr Cardiol       Date:  2019 Sep-Dec

5.  Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation.

Authors:  Waltraut M Merz; Christina Leufgen; Rolf Fimmers; Birgit Stoffel-Wagner; Ulrich Gembruch
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

6.  Assessing the consequences of gestational diabetes mellitus on offspring's cardiovascular health: MySweetHeart Cohort study protocol, Switzerland.

Authors:  Stefano Di Bernardo; Yvan Mivelaz; Adina Mihaela Epure; Yvan Vial; Umberto Simeoni; Pascal Bovet; Sandrine Estoppey Younes; Arnaud Chiolero; Nicole Sekarski
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.